These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 15714173)
1. Simultaneous development of lymphoma in recipients of renal transplants from a single donor: donor origin confirmed by human leukocyte antigen staining and microsatellite analysis. Caillard S; Pencreach E; Braun L; Marcellin L; Jaegle ML; Wolf P; Parissiadis A; Hannedouche T; Gaub MP; Moulin B Transplantation; 2005 Jan; 79(1):79-84. PubMed ID: 15714173 [TBL] [Abstract][Full Text] [Related]
2. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy. Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG; Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361 [TBL] [Abstract][Full Text] [Related]
3. Influence of host-recipient origin on clinical aspects of posttransplantation lymphoproliferative disorders in kidney transplantation. Petit B; Le Meur Y; Jaccard A; Paraf F; Robert CL; Bordessoule D; Labrousse F; Drouet M Transplantation; 2002 Jan; 73(2):265-71. PubMed ID: 11821742 [TBL] [Abstract][Full Text] [Related]
4. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin. Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335 [TBL] [Abstract][Full Text] [Related]
5. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients. Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV Nephrol Dial Transplant; 2012 Jul; 27(7):2971-9. PubMed ID: 22273720 [TBL] [Abstract][Full Text] [Related]
6. Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys. Schmidtko J; Wang R; Wu CL; Mauiyyedi S; Harris NL; Della Pelle P; Brousaides N; Zagachin L; Ferry JA; Wang F; Kawai T; Sachs DH; Cosimi BA; Colvin RB Transplantation; 2002 May; 73(9):1431-9. PubMed ID: 12023621 [TBL] [Abstract][Full Text] [Related]
7. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study. Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. Ellis D; Jaffe R; Green M; Janosky JJ; Lombardozzi-Lane S; Shapiro R; Scantlebury V; Vivas C; Jordan ML Transplantation; 1999 Oct; 68(7):997-1003. PubMed ID: 10532541 [TBL] [Abstract][Full Text] [Related]
9. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases. Babel N; Gabdrakhmanova L; Hammer M; Rosenberger C; Oppert M; Volk HD; Reinke P Transpl Infect Dis; 2005; 7(3-4):133-6. PubMed ID: 16390402 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients. Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128 [TBL] [Abstract][Full Text] [Related]
11. A poorly differentiated lymphoma of donor origin in a renal allograft recipient. Hjelle B; Evans-Holm M; Yen TS; Garovoy M; Guis M; Edman JC Transplantation; 1989 Jun; 47(6):945-8. PubMed ID: 2660355 [TBL] [Abstract][Full Text] [Related]
13. Microsatellite analysis in post-transplantation lymphoproliferative disorder to determine donor/recipient origin. Ng IO; Shek TW; Thung SN; Ye MM; Lo CM; Fan ST; Lee JM; Chan KW; Cheung AN Mod Pathol; 2000 Nov; 13(11):1180-5. PubMed ID: 11106074 [TBL] [Abstract][Full Text] [Related]
14. EBV-negative aggressive B-cell lymphomas of donor origin after allogeneic hematopoietic stem cell transplantation: a report of three cases. Federmann B; Bonzheim I; Schittenhelm J; Quintanilla-Martínez L; Mankel B; Vogel W; Faul C; Bethge W; Fend F Leuk Lymphoma; 2016 Nov; 57(11):2603-11. PubMed ID: 27049896 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 and posttransplant lymphoproliferative disorder after kidney transplantation. Birkeland SA; Bendtzen K; Møller B; Hamilton-Dutoit S; Andersen HK Transplantation; 1999 Mar; 67(6):876-81. PubMed ID: 10199737 [TBL] [Abstract][Full Text] [Related]
16. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation. Armes JE; Angus P; Southey MC; Battaglia SE; Ross BC; Jones RM; Venter DJ Cancer; 1994 Nov; 74(9):2436-41. PubMed ID: 7922997 [TBL] [Abstract][Full Text] [Related]